Uracil-tegafur and tamoxifen vs cyclophosphamide, methotrexate, fluorouracil, and tamoxifen in post-operative adjuvant therapy for stage I, II, or IIIA lymph node-positive breast cancer: a comparative study
Open Access
- 28 July 2009
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 101 (4), 598-604
- https://doi.org/10.1038/sj.bjc.6605218
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Adjuvant Chemotherapy in Older Women with Early-Stage Breast CancerThe New England Journal of Medicine, 2009
- Oral Uracil and Tegafur Compared With Classic Cyclophosphamide, Methotrexate, Fluorouracil As Postoperative Chemotherapy in Patients With Node-Negative, High-Risk Breast Cancer: National Surgical Adjuvant Study for Breast Cancer 01 TrialJournal of Clinical Oncology, 2009
- Adjuvant targeted therapy in early breast cancerCancer, 2009
- HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized TrialsJNCI Journal of the National Cancer Institute, 2008
- Taxanes for adjuvant treatment of early breast cancerEmergencias, 2007
- Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007Annals of Oncology, 2007
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Postoperative Adjuvant Therapy With Tamoxifen, Tegafur Plus Uracil, or Both in Women With Node-Negative Breast Cancer: A Pooled Analysis of Six Randomized Controlled TrialsJournal of Clinical Oncology, 2005
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 womenThe Lancet, 1992